Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVT PCV-25 in Healthy Infants
NCT06790290Phase 2Active, not recruiting
- Sponsor
- Inventprise
- Start
- Jan 2025
- Primary completion
- Apr 2025
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of IVT PCV-25 in invasive pneumococcal disease (IPD), sponsored by Inventprise. Started Jan 2025; status: active, not recruiting.
02
Drugs
IVT PCV-25
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT06790290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06790290.